These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5462887)

  • 21. Abstracts from the symposium Monoamine oxidase and disease: prospects for therapy with reversible inhibitors. Paris, October 26-28, 1983.
    Encephale; 1983; 9(2 Suppl 1):1A-98A. PubMed ID: 6641619
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of drugs on the accumulation and metabolism of extraneuronal norepinephrine in the rat heart.
    Eisenfeld AJ; Landsberg L; Axelrod J
    J Pharmacol Exp Ther; 1967 Dec; 158(3):378-85. PubMed ID: 4383722
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of different monoamine oxidase inhibitors on the metabolism of L-dopa in the rat brain.
    Nguyen TB; Angers M
    Biochem Pharmacol; 1987 May; 36(10):1731-5. PubMed ID: 3109430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of monoamine oxidase inhibitors on the rectal temperature of the rat.
    Summers RJ
    J Pharm Pharmacol; 1974 May; 26(5):335-43. PubMed ID: 4153112
    [No Abstract]   [Full Text] [Related]  

  • 25. Monoamine oxidase inhibitors and the extrapyramidal system.
    Gey KF; Pletscher A
    Pharmacol Ther B; 1976; 2(1):137-53. PubMed ID: 772716
    [No Abstract]   [Full Text] [Related]  

  • 26. The therapeutic potential of monoamine oxidase inhibitors.
    Youdim MB; Edmondson D; Tipton KF
    Nat Rev Neurosci; 2006 Apr; 7(4):295-309. PubMed ID: 16552415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drugs related to monoamine oxidase activity.
    Fišar Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():112-24. PubMed ID: 26944656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Vascular effects of monoamine oxidase inhibitors].
    Ackermann E
    Dtsch Gesundheitsw; 1965 Sep; 20(38):1758-66. PubMed ID: 5865209
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of pargyline on the response to CO2 stress].
    Alcalá T; Aguilar R; Bellido C
    Rev Esp Fisiol; 1985 Mar; 41(1):1-4. PubMed ID: 4001536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [On the effect of various digitalis substances on monoamine oxidase activity in rat, guinea pig and cat brain].
    Popov N; Förster W
    Acta Biol Med Ger; 1966; 17(2):221-31. PubMed ID: 5983237
    [No Abstract]   [Full Text] [Related]  

  • 31. The nature of inhibition of thyroid monoamine oxidase by thyroxine in rat thyroid.
    Knopp J
    Endokrinologie; 1982 Nov; 80(3):367-70. PubMed ID: 7166166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stress reduces in vivo inhibition of monoamine oxidase by phenelzine in rat brain.
    Clow A; Glover V; Oxenkrug GF; Sandler M
    Neurosci Lett; 1989 Dec; 107(1-3):331-4. PubMed ID: 2616044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proceedings: Monoamine oxidase from rat reticulocytes: subcellular localization of the enzyme activity and effects of irreversible non-hydrazine inhibitors.
    Quiring K; Hubertus S
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R83. PubMed ID: 1143505
    [No Abstract]   [Full Text] [Related]  

  • 34. Biochemical and pharmacological evaluation of 2,4-difluorobenzyldimethylsilylmethanamine, a new highly selective inhibitor of monoamine oxidase-B.
    Danzin C; Zreika M; Marchal P; Petty M; Collard JN; Schirlin D
    Biochem Soc Trans; 1994 Aug; 22(3):768-73. PubMed ID: 7821682
    [No Abstract]   [Full Text] [Related]  

  • 35. The mode of action of insulin potentiation by mebanazine.
    Barrett AM
    J Pharm Pharmacol; 1970 Apr; 22(4):291-7. PubMed ID: 4392571
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antihypertensive drugs].
    Peters G; Peters-Haefeli L
    Rev Med Suisse Romande; 1974 Aug; 94(8):589-614. PubMed ID: 4373810
    [No Abstract]   [Full Text] [Related]  

  • 37. [Monoamine oxidase and its inhibition (author's transl)].
    Gérardy J
    J Pharm Belg; 1980; 35(2):133-42. PubMed ID: 7391926
    [No Abstract]   [Full Text] [Related]  

  • 38. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
    Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cimoxatone is a reversible tight-binding inhibitor of the A form of rat brain monoamine oxidase.
    Fowler CJ; Strolin Benedetti M
    J Neurochem; 1983 Feb; 40(2):510-3. PubMed ID: 6822834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of monoamine oxidase by furazolidone in germfree rats.
    Yeung TC; Goldman P
    Biochem Pharmacol; 1981 Sep; 30(17):2496-7. PubMed ID: 21043255
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.